Journal of Jiangsu University(Medicine Edition), Volume. 35, Issue 4, 285(2025)
Celastrol induces ferroptosis in rituximab-resistant diffuse large B lymphoma cells by targeting the PI3K/Akt pathway
[1] [1] Candelaria M, Dueas-Gonzalez A. Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone(R-CHOP)in diffuse large B-cell lymphoma[J]. Ther Adv Hematol, 2021, 12(4): 112-120.
[2] [2] Park Sohee, Kim Ju Hwan, Kim Songhee, et al. Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study[J]. Blood Cancer J, 2023, 13: 123.
[3] [3] Shirai T, Nakai A, Ando E, et al. Celastrol suppresses humoral immune responses and autoimmunity by targeting the COMMD3/8 complex[J]. Sci Immunol, 2023, 8(81): eadc9324.
[6] [6] Zhao Z, Wang Y, Gong Y, et al. Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer[J]. J Transl Med, 2022, 20(1): 525.
[7] [7] Zhang X, Chen Y, Li X, et al. Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis[J]. Eur J Med Chem, 2024, 267: 116183.
[8] [8] Li H, Deng C, Zhu N, et al. An ultrasensitive GSH-specific fluorescent probe unveils celastrol-induced ccRCC ferroptosis[J]. Bioorg Chem, 2023, 134: 106454.
[9] [9] Jazirehi AR, Vega MI, Bonavida B. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy[J]. Cancer Res, 2007, 67(3): 1270-1281.
[10] [10] Krol AD, Ie Cessie S, Snijder S, et al. Primary extranodal non-Hodgkin′s lymphoma(NHL): the impact of alternative definitions tested in the comprehensive cancer centre west population-based NHL registry[J]. Ann Oncol, 2003, 14(1): 131-139.
[11] [11] Li X, Liu Z, Cao J, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai lymphoma research group[J]. Ann Hematol, 2012, 91(6): 837-845.
[12] [12] Feng X, Yin Z, Ou S, et al. The anti-tumor effects of Celastrus orbiculatusThunb. and its monomer composition: a review[J]. J Ethnopharmacol, 2023, 310: 116363.
[13] [13] Malfa GA, Tomasello B, Acquaviva R, et al.Betula etnensisRaf. (Betulaceae) extract induced HO-1 expression and ferroptosis cell death in human colon cancer cells[J]. Int J Mol Sci, 2019, 20(11): 2723-2730.
[14] [14] Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12(1): 34-40.
[15] [15] Chen H, He Y, Pan T, et al. Ferroptosis-related gene signature: a new method for personalized risk assessment in patients with diffuse large B-cell lymphoma[J]. Pharmgenomics Pers Med, 2021, 14: 609-619.
[16] [16] Zhang Y, Tan H, Daniels JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model[J]. Cell Chem Biol, 2019, 26(5): 623-633.
[17] [17] Schmitt A, Xu W, Bucher P, et al. Dimethyl fumarate induces ferroptosis and impairs NF-B/STAT3 signaling in DLBCL[J]. Blood, 2021, 138(10): 871-884.
[20] [20] Havranek O, Xu J, Khrer S, et al. Tonic B-cell receptor signaling in diffuse large B-cell lymphoma[J]. Blood, 2017, 130(8): 995-1006.
[21] [21] Yang L, Liu Y, Wang M, et al. Celastrus orbiculatus extract triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in human colorectal cancer cells[J]. Oncol Lett, 2016, 12(5): 3771-3778.
[22] [22] Feng X, Yin Z, Ou S, et al. The anti-tumor effects of Celastrus orbiculatus Thunb. and its monomer composition: A review[J]. J Ethnopharmacol, 2023, 310: 116363.
Get Citation
Copy Citation Text
LIU Xianhai, SUN Xiaolin, HU Jiabo, XU Pei. Celastrol induces ferroptosis in rituximab-resistant diffuse large B lymphoma cells by targeting the PI3K/Akt pathway[J]. Journal of Jiangsu University(Medicine Edition), 2025, 35(4): 285
Special Issue:
Received: May. 10, 2024
Accepted: Aug. 21, 2025
Published Online: Aug. 21, 2025
The Author Email: XU Pei (106938907@qq.com)